Psilocybin Therapy & Treatment

This article explores psilocybin’s potential to treat various anxiety disorders—from GAD and social anxiety to terminal illness distress—highlighting clinical and real-world results.

This informative article examines how psilocybin mushrooms work in therapeutic settings, including onset times, peak effects, and duration. Learn about important timing considerations for treatment sessions, physiological factors that influence experiences, and safety protocols essential for therapeutic applications.

In this article, we introduce OCD, review the published literature on psilocybin for OCD, discuss potential mechanisms of action, provide an overview of ongoing research, and highlight the experience of a former Odyssey client whose OCD symptoms vastly improved after their psilocybin session.

In this article, we describe the condition of depression, review the published literature on psilocybin for depression, and discuss potential mechanisms of action. We then provide an overview of the efficacy and benefits, protocol and dosage, and side effects of psilocybin for depression, based on existing research.

Colorado is one such state where policymakers have made inroads, and this article will explore how interested residents can maintain compliance with current laws, prepare for changes, and pursue this life-changing treatment for themselves.

Oregon has become a pioneer in the United States by legalizing psilocybin and regulating its use for therapeutic purposes, sparking interest among those seeking alternative methods to improve their mental well-being.

In this guide, we will explore the current status of psilocybin in California, the legal landscape, and its therapeutic potential for mental health conditions.

This study aimed to investigate the relationship between the therapeutic alliance between participants and intervention facilitators, and the clinical outcomes in a psilocybin-assisted therapy trial for individuals diagnosed with major depressive disorder.

Published in the prestigious medical journal JAMA Network, this study explored whether psilocybin therapy could help healthcare professionals struggling with depression after working on the frontline during the COVID-19 pandemic.

This study highlights psilocybin’s potential to support both individuals actively struggling with AN and those in partial remission who continue to face mental and emotional challenges.

A recent review published in the Journal of Pharmacology and Experimental Therapeutics delves into the potential of psilocybin as a promising treatment for post-traumatic stress disorder (PTSD), focusing on its behavioral effects, underlying mechanisms, current challenges, and future directions

Psilocybin, a classic psychedelic compound, has emerged as a potential breakthrough treatment for mental health conditions such as treatment-resistant depression (TRD), anxiety, and PTSD. Clinical trials have shown promising results, with rapid and sustained improvements in mood and overall well-being following psilocybin-assisted therapy